Vault-13

Wave Life Sciences Inc. WVE

COM · Common Stock · CUSIP 94352A104

Biotechnology company

1 institutional holders
429,121429.1k shares reported held*
0.2% of all shares outstanding*
$2.5mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 197.0m as of 2026-07-23, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $5.81.

Biggest buyers

KENNEDY CAPITAL MANAGEMENT LLC New +429,121+429.1k

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence filed 2026-08-11
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: On August 7, 2026, as part of the Redomiciliation, Wave-Delaware, became the ultimate parent company of the Wave Life Sciences group of companies. Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of Wave Life Sciences Ltd. ("Wave-Singapore") as of immediately prior to the effective time of the Scheme of Arrangement were exchanged on a one-for-one basis for newly issued shares of common stock, par value $0.001 per share, of Wave-Delaware, and Wave-Singapore became a wholly owned subsidiary of Wave-Delaware. Full filing
 16.8% 34.3m 2026-08-11
BlackRock, Inc. 13G · institution new · filed 2026-10-27 6.8% new 13.4m 2026-10-27

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
10010Q4 24: 0 buyingQ4 24: 2 sellingQ1 25: 0 buyingQ1 25: 2 sellingQ1 25Q2 25: 0 buyingQ2 25: 1 sellingQ3 25: 0 buyingQ3 25: 5 sellingQ3 25Q4 25: 1 buyingQ4 25: 8 sellingQ1 26: 1 buyingQ1 26: 4 sellingQ1 26Q2 26: 0 buyingQ2 26: 0 sellingQ3 26: 0 buyingQ3 26: 4 sellingQ3 26
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20240—2$6.3m$6.3m
Q1 20250—2$1.7m$1.7m
Q2 20250—1$208.5k$208.5k
Q3 20250—5$2.6m$2.6m
Q4 20251$6.7k8$9.7m$9.7m
Q1 20261$54.6m4$907.7k$649.8k
Q2 20260—0——
Q3 20260—4$135.1k$135.1k
DateInsiderTradeSharesPrice ValueTheir holding
2026-08-12 Rawcliffe Adrian Director Sold plan 12,700 $5.29 $67.2k12.7k shares -100%
2026-08-11 Wagner Heidi L Director Sold plan 7,000 $6.01 $42.1k7.0k shares -14%
2026-08-11 TAKANASHI KEN Director Sold plan 3,864 $6.01 $23.2k3.9k shares -16%
2026-08-11 Tan Aik Na Director Sold plan 432 $6.01 $2.6k432 shares -2%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 KENNEDY CAPITAL MANAGEMENT LLC 0.04% of their portfolio ST LOUIS, MO 429,121429.1k $2.5m $2.5m 0.04% New